PropertyValue
?:abstract
  • The 2019 coronavirus (SARS-CoV-2) has been declared a public health emergency of international concern by the World Health Organization Due to the sudden appearance of this pandemic process associated with increasing morbidity and mortality worldwide, various treatments have been implemented In this framework, high doses of vitamin C began to be used in critically ill patients We analyze the clinical trials and/or research papers available in the literature Although more evidence on its effectiveness is needed is important for the specialist to understand the clinical logic of this use to determine if it is correct as a concomitant treatment Conclusions: It seems that using high doses of vitamin C parenterally is a safe, available and economical alternative especially for critically ill patients
is ?:annotates of
?:creator
?:journal
  • Ars_Pharmaceutica
?:license
  • unk
?:publication_isRelatedTo_Disease
?:source
  • WHO
?:title
  • High dose of ascorbic acid used in Sars Covid-19 treatment: Scientific and clinical support for its therapeutic implementation
?:type
?:who_covidence_id
  • #737040
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/e97ygle2>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/e97ygle2>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all